CRISPR/Cas9 genome editing is used to introduce a null frameshift mutation. Specifically, a 3 bp deletion followed by a 1 bp insertion and a 9 bp deletion in exon 2 that is predicted to result in an alanine 129 frameshift that adds 43 new amino acids and results in premature termination. (J:101977)